Skip to main content
PeptiDex Logo

PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Privacy & Terms
Home
Library
StartToolsSaved
Back to Library

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

KPV

Also: Lys-Pro-Val

🩹Anti-Inflammatory

How It Works

Alpha-MSH fragment that potently suppresses NF-κB inflammatory signaling. Reduces pro-inflammatory cytokines and promotes mucosal healing.

Primary Benefits

1Gut/injury healing
2inflammation reduction

Key Studies

KPV anti-inflammatory effects in murine colitis

Dalmasso et al. (PLoS One): KPV demonstrates significant anti-inflammatory effects in murine models of inflammatory bowel disease, suppressing NF-κB and MAPK pathways.

preclinical

KPV suppresses NF-κB signaling in airway epithelium

Study shows KPV inhibits p65RelA nuclear import, suppressing NF-κB inflammatory signaling in airway epithelial cells — relevant to respiratory and gut inflammation.

preclinical

KPV-loaded nanoparticles for oral IBD treatment

Hyaluronic acid-functionalized nanoparticle delivery of KPV enhances oral bioavailability and anti-inflammatory efficacy in colitis models, supporting clinical translation.

preclinical

KPV reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α)

KPV selectively suppresses production of IL-1β, IL-6, IL-12, TNF-α, and IFN-γ in colonic epithelial and immune cells, with effects mediated via intracellular PepT1 transport.

preclinical

Safety Notes

Excellent profile. Research-only compound with limited human data but strong preclinical safety.

Dosing Protocol

⚠️ For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide.

RouteSubQ
Dose Range200-500 mcg
FrequencyDaily
TimingAny time
Cycle Length4-12 weeks
BAC Water2 ml / 5mg vial

Often used orally in capsules for gut-specific effects. SubQ for systemic anti-inflammatory.

Half-Life Visualization

⏱️ Half-Life: 30min

Plasma concentration over time
100%50%0%0t½ = 30min

Legal Status by Country

🇺🇸USA
Research Only
🇨🇦Canada
Research Only
🇬🇧UK
Unregulated
🇪🇺EU
Unregulated
🇦🇺Australia
Research Only

Last updated: 2026-01 · Laws change frequently. Verify current status in your jurisdiction.

Expected Timeline

Week 1

Potent anti-inflammatory effect; rapid symptom relief in gut/injury

Weeks 2-4

Mucosal healing acceleration; reduced IBD flare symptoms

Month 2-3

Wound healing and IBD remission in study models; sustained anti-inflammatory effect

Side Effects & Incidence

Side EffectIncidenceSeverity

Generally very well-tolerated

Very limited human datamild

Mild GI adjustment

~5% of users (oral route)mild

Incidence rates sourced from published clinical trial data where available; otherwise based on community research observations.

Found in 2 Stacks

Injury Recovery Stack

Accelerate healing of musculoskeletal injuries including tendons, ligaments, muscles, and post-surgical recovery

BPC-157TB-500KPVSS-31

Gut Health & Recovery Stack

Repair and protect the gastrointestinal lining and reduce GI inflammation

BPC-157KPVThymosin Alpha-1

Weekly Peptide Research

New studies · vendor alerts · protocol tips

No spam. Unsubscribe anytime. Research use only.